Sherezade Moñino-Romero
9PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Oct 28, 2025
Release of Mast Cell Mediators from Cochlear Tissue Following Short Exposure to Compound 48/80 or Cisplatin, and Their Damage to Cochlear Structure.Bin Zeng, Stefan Frischbutter, Sherezade Moñino-Romero
|Aug 29, 2023
Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria.S Moñino-Romero, P Kolkhir, T Ohanyan
|Feb 24, 2023
Soluble IgE-binding factors in the serum of food-allergic patients: Possible pathophysiological role of soluble FcεRI as protective factor.Carolin Steinert, Sherezade Moñino-Romero, Monique Butze
|Feb 17, 2022
Bruton's tyrosine kinase inhibition-An emerging therapeutic strategy in immune-mediated dermatological conditions.Pedro Mendes-Bastos, Ana Brasileiro, Pavel Kolkhir
|Jan 21, 2021
Total IgE as a Marker for Chronic Spontaneous Urticaria.Sabine Altrichter, Jie Shen Fok, Qingqing Jiao
|Jul 22, 2018
The soluble isoform of human FcɛRI is an endogenous inhibitor of IgE-mediated mast cell responses.S Moñino-Romero, L Erkert, K Schmidthaler
Pageof 2
Frequent Collaborators
5 joint publications
Jörg Scheffel
5 joint publications
Marcus Maurer
3 joint publications
Pavel Kolkhir
3 joint publications
Sabine Altrichter
3 joint publications
Frank Siebenhaar
2 joint publications
Dorothea Terhorst-Molawi
2 joint publications
Edda Fiebiger
2 joint publications
Zsolt Szépfalusi
2 joint publications
Carolin Steinert
2 joint publications
Martin Metz
